BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28133619)

  • 1. From Humoral Theory to Performant Risk Stratification in Kidney Transplantation.
    Lefaucheur C; Viglietti D; Mangiola M; Loupy A; Zeevi A
    J Immunol Res; 2017; 2017():5201098. PubMed ID: 28133619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation.
    Viglietti D; Lefaucheur C; Glotz D
    Curr Opin Organ Transplant; 2016 Aug; 21(4):433-40. PubMed ID: 27348472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of C1q Binding Status With De Novo HLA Antibody Clinical Features and Allograft Function in Kidney Transplantation Patients During Eight Years of Dynamic Follow-up.
    Wei X; Yuan X; Sun M; Pan Z; Hu L; Wang L; He J; Hou J
    Transplant Proc; 2016; 48(6):1944-54. PubMed ID: 27569927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclass analysis of donor HLA-specific IgG in antibody-incompatible renal transplantation reveals a significant association of IgG4 with rejection and graft failure.
    Khovanova N; Daga S; Shaikhina T; Krishnan N; Jones J; Zehnder D; Mitchell D; Higgins R; Briggs D; Lowe D
    Transpl Int; 2015 Dec; 28(12):1405-15. PubMed ID: 26264744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared alloimmune responses against blood and transplant donors result in adverse clinical outcomes following blood transfusion post-renal transplantation.
    Hassan S; Regan F; Brown C; Harmer A; Anderson N; Beckwith H; Roufosse CA; Santos-Nunez E; Brookes P; Taube D; Willicombe M
    Am J Transplant; 2019 Jun; 19(6):1720-1729. PubMed ID: 30582278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
    Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-fixing donor-specific anti-HLA antibodies and kidney allograft failure.
    Cazarote HB; Shimakura S; Valdameri JS; Contieri FLC; von Glehn CQC; Aita CM; Susin MF; Sotomaior VS; Glehn-Ponsirenas R
    Transpl Immunol; 2018 Aug; 49():33-38. PubMed ID: 29596992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.
    Lefaucheur C; Viglietti D; Bentlejewski C; Duong van Huyen JP; Vernerey D; Aubert O; Verine J; Jouven X; Legendre C; Glotz D; Loupy A; Zeevi A
    J Am Soc Nephrol; 2016 Jan; 27(1):293-304. PubMed ID: 26293822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
    Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Transpl Immunol; 2015 Mar; 32(2):66-71. PubMed ID: 25661873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens.
    Abuhelaiqa E; Friedlander R; Aull M; Putheti P; Sharma V; Suthanthiran M; Dadhania D
    Clin Transpl; 2016; 32():83-91. PubMed ID: 28564525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-binding anti-HLA antibodies and kidney-allograft survival.
    Loupy A; Lefaucheur C; Vernerey D; Prugger C; Duong van Huyen JP; Mooney N; Suberbielle C; Frémeaux-Bacchi V; Méjean A; Desgrandchamps F; Anglicheau D; Nochy D; Charron D; Empana JP; Delahousse M; Legendre C; Glotz D; Hill GS; Zeevi A; Jouven X
    N Engl J Med; 2013 Sep; 369(13):1215-26. PubMed ID: 24066742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
    Marfo K; Ajaimy M; Colovai A; Kayler L; Greenstein S; Lubetzky M; Gupta A; Kamal L; de Boccardo G; Masiakos P; Kinkhabwala M; Akalin E
    Transplantation; 2014 Nov; 98(10):1082-8. PubMed ID: 24873780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management.
    McCaughan JA; Tinckam KJ
    Transpl Int; 2018 Oct; 31(10):1059-1070. PubMed ID: 30062683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral Immune Response and Allograft Function in Kidney Transplantation.
    Filippone EJ; Farber JL
    Am J Kidney Dis; 2015 Aug; 66(2):337-47. PubMed ID: 25987262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of donor-specific antibody with low mean fluorescence intensity on allograft outcomes in kidney transplant.
    Kitpermkiat R; Kantachuvesiri S; Thotsiri S; Thammanichanond D; Rostaing L; Wiwattanathum P
    Transpl Immunol; 2024 Jun; 84():102054. PubMed ID: 38750972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.